title: Editorial Comment to Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery.
authors.affiliation: Division of Urology, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA; Surgery Section, Durham VA Medical Center, Durham, North Carolina, USA.
authors.forename: Ross M
authors.initials: RM
authors.lastname: Simon
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Freedland
authors.forename: Adriana C
authors.initials: AC
authors.lastname: Vidal
mesh_terms: D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D016879:Salvage Therapy / Q000379:methods*
chemical_list: D017430:Prostate-Specific Antigen